University of Calgary, Foothills Medical Centre, Calgary, Alberta, T2N 2T9 Canada.
J Am Soc Nephrol. 2011 Aug;22(8):1534-42. doi: 10.1681/ASN.2010121232. Epub 2011 Jul 22.
The relative risk of death for patients treated with peritoneal dialysis compared with those treated with hemodialysis appears to change with duration of dialysis therapy. Patients who start dialysis urgently are at high risk for mortality and are treated almost exclusively with hemodialysis, introducing bias to such mortality comparisons. To better isolate the association between dialysis treatment modality and patient mortality, we examined the relative risk for mortality for peritoneal dialysis compared with hemodialysis among individuals who received ≥4 months of predialysis care and who started dialysis electively as outpatients. From a total of 32,285 individuals who received dialysis in Ontario, Canada during a nearly 8-year period, 6,573 patients met criteria for elective, outpatient initiation. We detected no difference in survival between peritoneal dialysis and hemodialysis after adjusting for relevant baseline characteristics. The relative risk of death did not change with duration of dialysis therapy in our primary analysis, but it did change with time when we defined our patient population using the more inclusive criteria typical of previous studies. These results suggest that peritoneal dialysis and hemodialysis associate with similar survival among incident dialysis patients who initiate dialysis electively, as outpatients, after at least 4 months of predialysis care. Selection bias, rather than an effect of the treatment itself, likely explains the previously described change in the relative risk of death over time between hemodialysis and peritoneal dialysis.
与血液透析相比,接受腹膜透析治疗的患者的死亡相对风险似乎随透析治疗时间的延长而变化。紧急开始透析的患者死亡率高,几乎完全接受血液透析治疗,这给此类死亡率比较带来了偏倚。为了更好地将透析治疗方式与患者死亡率联系起来,我们检查了在接受至少 4 个月的透析前护理并作为门诊患者择期开始透析的患者中,与血液透析相比,腹膜透析的死亡率相对风险。在加拿大安大略省近 8 年的时间里,共有 32285 人接受了透析治疗,其中有 6573 名患者符合择期、门诊开始的标准。在调整了相关基线特征后,我们没有发现腹膜透析和血液透析之间的生存差异。在我们的主要分析中,透析治疗时间的长短与死亡的相对风险没有关系,但当我们使用之前研究中更常见的更具包容性的标准来定义患者人群时,这种关系随时间而变化。这些结果表明,在接受至少 4 个月的透析前护理并作为门诊患者择期开始透析的新透析患者中,腹膜透析和血液透析与相似的生存率相关。与时间相关的死亡相对风险的变化可能是由于选择偏倚,而不是治疗本身的影响,这可能解释了之前描述的血液透析和腹膜透析之间相对风险随时间变化的情况。